Funding Received
$5.2 Million in 2 Rounds from 5 Investors
Most Recent Funding
$2.2 Million Grant on June 9, 2014
Headquarters:
Snodland
Description:
MGB Biopharma develops DNA minor groove binders-based anti-infective medicines.
Categories:
Biotechnology
Website:
http://www.mgb-biopharma.com

Detailed Description

Update

MGB Biopharma Limited is a biopharmaceutical company established to develop a completely new class of anti-infective medicines based upon compounds which are DNA Minor Groove Binders (MGB)

The company has an exceptionally experienced team from both pharma and biotech sectors and is dedicating its focus initially to the development of small molecules with specific antibacterial efffects against resistant bacteria

By selecting a new class of antibacterial, the company believes the novel mode of action should prove to be very potent against bacteria as these target organisms will lack any inherent resistance, unlike that typically facing new drugs which are the result of modifications from existing classes of drugs used to treat bacterial infection

Current Team (3)

Update

Investors (5)

Update

Offices/Locations (1)

Update
  • Office

    151 West George Street

    Glasgow

    Snodland, G2 2JJ

    GBR